Stressed Out and Locked-Down During Pandemic, New Yorkers Craved Alcohol, YSPH Study Finds
As New York state’s lockdown orders wore on in the early months of the COVID-19 pandemic, residents increasingly felt cravings for alcohol — and reported subsequently misusing it, a new study from scientists at the Yale School of Public Health and Stony Brook University has found.
Pandemic-based Approach to Methadone Treatment Restrictions Should Remain, YSPH Study Finds
When the COVID-19 pandemic ripped through New England and the rest of the United States in early 2020, substance use disorder treatment centers were forced to make massive changes to minimize the spread of coronavirus.
The Overdose Crisis: Harm Reduction in U.S. Health Policy
On May 20, Yale’s Department of Internal Medicine and Program in Addiction Medicine hosted its first event on Clubhouse, a social networking app that allows members to gather in audio chat rooms and discuss issues in a live podcast style. The event focused on the drug overdose in the United States and incorporation of harm reduction into U.S. health policy and practice.
WHRY Funds Studies on Heart Disease, Insomnia, and Pain
Women’s Health Research at Yale today announced funding for three new studies investigating a method for improving the diagnosis of heart disease in women, a therapy for clinically significant sleep disruption common in Black women, and the influence of biological sex on the underlying brain patterns that link pain and opioid use.
Addiction Psychiatry Division Will Participate in Consortium to Develop New Treatment Tools for Addiction
Yale School of Medicine’s Division of Addiction Psychiatry will participate in a consortium funded by a multimillion-dollar federal grant that will attempt to develop new treatment tools for addiction.
$15M NIDA Grant Awarded to Serena Spudich, Mark Gerstein, and Yuval Kluger
Principal Investigators Serena Spudich, MD, MA (Neurology), Mark Gerstein, PhD (Molecular Biophysics and Biochemistry), and Yuval Kluger, PhD (Pathology) were recently awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to establish a Data Center to coordinate, analyze, and make accessible single-cell and other molecular data sets generated by Single-Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects.
WHRY Funds Studies on Stroke, Endometrial Cancer, and Addiction to Opioids
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
Yale Scientists Awarded $8.4M Grant to Develop Treatments for Women With Problem Drinking
Yale Department of Psychiatry scientists have been awarded a five-year, $8.4 million federal grant to establish a new research center at Yale that will develop treatments to help women with problem drinking.
Teen vaping is bad. Nicotine makes it worse, says researcher
Companies that make vaping liquids must now comply with a U.S. Food and Drug Administration policy released last month banning vape liquids that taste like anything but tobacco or menthol. But vaping still delivers something highly appealing and addictive: nicotine. And researchers are just beginning to study the drug’s long-term impact on the developing brain.Source: Science Mag
School of Nursing Lecture Presentation on Feb. 12: "Women, HIV, and Opiate Use Disorder: Bringing Healing to the Center of Care: An Integrated Trauma-informed Behavioral Health Approach"
This lecture, by Rosalind de Lisser, MS, FNP-BC, PMHNP-BC, will be presented at Yale School of Nursing, 400 West Campus Drive, Orange, CT, and made available by Livestream.
Ending Stigma, Saving Lives: Yale Doctors Take on Opioid Addiction
On the lapel of her blazer, Dr. Gail D’Onofrio wears a button bearing one word with a line through it: stigma. D’Onofrio, who chairs Yale’s Department of Emergency Medicine, works to improve outcomes for people with opioid use disorder, and she’s on a crusade against stigma for a simple reason: social fear hinders treatment.
Are Benzodiazepines the New Opioids?
Yale addiction specialists believe the primary care system can play a key role in preventing another medication epidemic. David A. Fiellin, MD, worries that otherwise, the trajectory of benzodiazepine prescriptions might lead to a situation that resembles the opioid crisis.Source: Yale Medicine
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.